TD Asset Management Inc Decreases Stock Position in Oscar Health, Inc. (NYSE:OSCR)

Key Points

• TD Asset Management Inc reduced its holdings in Oscar Health, Inc. (NYSE:OSCR) by 6.8% in Q1, owning 673,232 shares valued at approximately $8.83 million after a sale of 49,208 shares.
• Oscar Health's quarterly earnings surpassed expectations with earnings per share of $0.92, exceeding the consensus estimate of $0.83, while net revenue increased 42.2% year-over-year to $3 billion.
• Analysts have a consensus rating of "Hold" on Oscar Health stock, with target prices ranging as low as $11.00 following recent downgrades from several firms.

TD Asset Management Inc trimmed its position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 6.8% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 673,232 shares of the company's stock after selling 49,208 shares during the period. TD Asset Management Inc owned 0.27% of Oscar Health worth $8,826,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Larson Financial Group LLC boosted its holdings in shares of Oscar Health by 83,733.3% in the first quarter. Larson Financial Group LLC now owns 2,515 shares of the company's stock worth $33,000 after acquiring an additional 2,512 shares during the period. CWM LLC boosted its holdings in shares of Oscar Health by 50.7% in the first quarter. CWM LLC now owns 3,204 shares of the company's stock worth $42,000 after acquiring an additional 1,078 shares during the period. Princeton Global Asset Management LLC bought a new position in shares of Oscar Health in the first quarter worth $59,000. GAMMA Investing LLC boosted its holdings in shares of Oscar Health by 2,156.4% in the first quarter. GAMMA Investing LLC now owns 6,476 shares of the company's stock worth $85,000 after acquiring an additional 6,189 shares during the period. Finally, Tower Research Capital LLC TRC boosted its holdings in shares of Oscar Health by 171.4% in the fourth quarter. Tower Research Capital LLC TRC now owns 6,627 shares of the company's stock worth $89,000 after acquiring an additional 4,185 shares during the period. 75.70% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages recently issued reports on OSCR. Wall Street Zen downgraded Oscar Health from a "buy" rating to a "hold" rating in a research report on Sunday, June 8th. Raymond James Financial downgraded Oscar Health from an "outperform" rating to a "market perform" rating in a research report on Tuesday, June 24th. Robert W. Baird reiterated a "neutral" rating and issued a $14.00 price objective (down previously from $28.00) on shares of Oscar Health in a research report on Friday, July 25th. Wells Fargo & Company downgraded Oscar Health from an "equal weight" rating to an "underweight" rating and lowered their price objective for the stock from $16.00 to $10.00 in a research report on Friday, July 11th. Finally, UBS Group reiterated a "sell" rating and issued a $11.00 price objective (down previously from $15.00) on shares of Oscar Health in a research report on Tuesday, July 15th. Five equities research analysts have rated the stock with a sell rating and five have given a hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $12.21.

Oscar Health Price Performance

NYSE OSCR traded up $0.27 during trading hours on Monday, reaching $13.85. 13,536,917 shares of the stock traded hands, compared to its average volume of 12,956,648. The stock has a 50 day simple moving average of $15.86 and a two-hundred day simple moving average of $14.89. Oscar Health, Inc. has a 1 year low of $11.20 and a 1 year high of $23.79. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.88 and a quick ratio of 0.88. The company has a market cap of $3.53 billion, a price-to-earnings ratio of 49.46 and a beta of 1.86.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share for the quarter, beating analysts' consensus estimates of $0.83 by $0.09. The business had revenue of $3 billion for the quarter, compared to the consensus estimate of $2.87 billion. Oscar Health had a return on equity of 10.59% and a net margin of 1.22%. The company's revenue for the quarter was up 42.2% on a year-over-year basis. During the same quarter last year, the business posted $0.62 earnings per share. On average, analysts predict that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Insider Activity at Oscar Health

In other news, Director Elbert O. Jr. Robinson sold 25,000 shares of Oscar Health stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $16.43, for a total value of $410,750.00. Following the transaction, the director owned 64,512 shares in the company, valued at approximately $1,059,932.16. The trade was a 27.93% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 24.39% of the company's stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.